Skip to main navigation menu Skip to main content Skip to site footer

Mitochondria: from the cell to the clinic; case of sepsis

Mitocodria: de la célula al clínica, caso de la sepsis




Section
Artículos de Revisión

How to Cite
Sánchez Díaz, E., Gallego González, D., Marín Cárdenas, J. S., & Agudelo Vélez, C. A. (2014). Mitochondria: from the cell to the clinic; case of sepsis. Archivos De Medicina , 14(2), 285-296. https://doi.org/10.30554/archmed.14.2.268.2014
Download Citation

Dimensions
PlumX

How to Cite

Sánchez Díaz, E., Gallego González, D., Marín Cárdenas, J. S., & Agudelo Vélez, C. A. (2014). Mitochondria: from the cell to the clinic; case of sepsis. Archivos De Medicina , 14(2), 285-296. https://doi.org/10.30554/archmed.14.2.268.2014

Download Citation

Emmanuel Sánchez Díaz
Daniel Gallego González
Juan Sebastián Marín Cárdenas
Camilo Andrés Agudelo Vélez

Emmanuel Sánchez Díaz,

Estudiante de medicina. Grupo de Investigación de Biología de Sistemas, Escuela de Ciencias de la Salud, Universidad Pontificia Bolivariana. Medellín, Colombia.

Daniel Gallego González,

Estudiante de medicina. Grupo de Investigación de Biología de Sistemas, Escuela de Ciencias de la Salud, Universidad Pontificia Bolivariana. Medellín, Colombia.

Juan Sebastián Marín Cárdenas,

Estudiante de medicina. Grupo de Investigación de Biología de Sistemas, Escuela de Ciencias de la Salud, Universidad Pontificia Bolivariana. Medellín, Colombia.

Camilo Andrés Agudelo Vélez,

Médico, MSc en Administración en Servicios de Salud. Coordinador de Gestión Clínica, Clínica Universitaria Bolivariana, Universidad Pontificia Bolivariana. Medellín, Colombia.

Most read articles by the same author(s)

Mitochondria has been identified as a key organelle in the pathophysiological process of several clinical disorders, especially those ones that involves metabolic processes.Multiple mechanisms, such as metabolic pathways of biological interactions, havebeen described in severe systemic inflammatory disorders such as sepsis. Particularly, the mean role of the oxidative stress as a marker of mitochondrial dysfunction has elucidated molecular target of clinical interest. From these considerations, it has been possible to synthesize molecules with selective therapeutic activity to counteract the mitochondrial alterations and thereby improve the prognosis and survival of patients suffering from high morbidity and mortality diseases, providing a sample scenario of the knowledge evolution from the cell to the clinical situation in a septic patient.

Article visits 1460 | PDF visits 578


Downloads

Download data is not yet available.